Arcus Biosciences, Inc.’s $302.5 Million Follow-on Offering

Gunderson Dettmer advised the underwriters. Arcus Biosciences announced the follow-on public offering of 11,000,000 shares at $27.50 per share with aggregate gross proceeds of approximately $302.5…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now